Brandon Hudgins to Receive NORD Rare Impact Award at May 18th Ceremony

On  Thursday, May 18,  Brandon Hudgins will be accepting the NORD 2017 Rare Impact Award.   The VF  nominated Brandon, a record-breaking, elite runner, for his work raising awareness about vasculitis, and the Vasculitis Foundation.

Hudgins was diagnosed with GPA Wegener’s Vasculitis in 2008.  Despite the illness, he  became one of only 449 Americans to race a mile in under four minutes and earned a spot in the 2016 Olympic Trials.   In April of 2016, Hudgins joined the VF on a new campaign called,  Victory Over Vasculitis:  VF Team Brandon.   As the leader of this virtual team with members throughout the world, Hudgins challenged vasculitis patients to define their own personal victory over vasculitis, and set out to accomplish it.  

The Rare Impact Awards serves as NORD’s signature fundraising event in which it brings together the entire rare disease community to celebrate people and organizations who are making extraordinary contributions to help others. This event also serves as an opportunity to individually and collectively renew our commitment, energy, and focus to provide critical services to help the 30 million Americans with rare diseases.

The Rare Impact Awards will be live-streamed beginning at 7:30 p.m.   Click here to watch the ceremony.   Brandon will accept his award at approximately 8:45 p.m., ET.


Vasculitis Foundation

The Vasculitis Foundation is the international organization for patients with vasculitis, their families, friends and the health care professionals who care for them.

VF Announces 2018 V-RED Awardees

The Vasculitis Foundation is pleased to announce Dr. Linda Brady, a pediatrician with Vanderbilt, is the winner of its 2018 Recognizing Excellence in Diagnostics (V-RED) Award.  The award is presented annually to more »

VF Celebrates Vasculitis Awareness Month 2018

The Vasculitis Foundation, the world’s largest organization dedicated to providing advocacy, education and support for people with vasculitis, announces the launch of Vasculitis Awareness Month (May 2018), an annual effort more »

#GivingTuesday Matching Gift Challenge

#GivingTuesday is a global day of giving fueled by the power of social media and collaboration.  This year your donation can go even further with our generous matching gift challenge! more »

Introducing our 2017-2018 VCRC-VF Fellow

Kaitlin Quinn, MD, is the recipient of the 2017 VCRC-VF Fellowship.  She received her medical degree from New York Medical College in Valhalla, New York.   She completed her Internal Medicine more »

FDA Approves Genentech’s Actemra® for Giant Cell Arteritis

Genentech, a member of the Roche Group, announced today (May 22, 2017) that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) subcutaneous injection for the treatment of more »